++
Chapter 4. Risk Assessment
++
++
++
Which of the following is NOT important in hazard identification?
+
+
++
a. structure–activity analysis.
+
++
+
++
+
++
+
++
++
++
++
The probability of an adverse outcome is defined as:
+
+
++
+
++
+
++
+
++
+
++
++
++
++
The systematic scientific characterization of adverse health effects resulting from human exposure to hazardous agents is the definition of:
+
+
++
+
++
+
++
+
++
+
++
++
++
++
Which of the following is not an objective of risk management?
+
+
++
a. setting target levels for risk.
+
++
b. balancing risks and benefits.
+
++
c. calculating lethal dosages.
+
++
d. setting priorities for manufacturers.
+
++
e. estimating residual risks.
++
++
++
Which of the following is NOT a feature in the design of standard cancer bioassays?
+
+
++
a. more than one species.
+
++
+
++
c. near lifetime exposure.
+
++
d. approximately 50 animals per dose group.
+
++
e. same dose level for all groups.
++
++
++
Which of the following types of epidemiologic study is always retrospective?
+
+
++
+
++
+
++
+
++
+
++
++
++
++
Which of the following is defined as the highest nonstatistically significant dose tested?
+
+
++
+
++
+
++
+
++
+
++
++
++
++
Which of the following represents the dose below which no additional increase in response is observed?
+
+
++
+
++